Cargando…
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
BACKGROUND: Tocilizumab and baricitinib are recommended treatment options for hospitalized COVID-19 patients requiring oxygen support. Literature about its efficacy and safety in a head-to-head comparison is scarce. METHODS: Hospitalized COVID-19 patients requiring oxygen were treated with tocilizum...
Autores principales: | Karolyi, Mario, Gruebl, Andreas, Omid, Sara, Saak, Magdalena, Pawelka, Erich, Hoepler, Wolfgang, Kelani, Hasan, Kuran, Avelino, Laferl, Hermann, Ott, Clemens, Pereyra, David, Santol, Jonas, Seitz, Tamara, Traugott, Marianna, Assinger, Alice, Wenisch, Christoph, Zoufaly, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461450/ https://www.ncbi.nlm.nih.gov/pubmed/36083403 http://dx.doi.org/10.1007/s15010-022-01915-7 |
Ejemplares similares
-
Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
por: Karolyi, M., et al.
Publicado: (2020) -
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022) -
Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report
por: Hoepler, Wolfgang, et al.
Publicado: (2021) -
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients: Results from a real-life patient cohort
por: Karolyi, Mario, et al.
Publicado: (2020) -
COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)